Empowering the Voice of Kansas Pharmacy

Log in

Latest News

Pharmacy News & Notes

Share your news with KPhA! Submit an announcement.

  • 03/25/2014 12:06 PM | Anonymous

    Kansas legislators have been busy this session with a number of important bills being considered. The pharmacy related bills will have an impact on pharmacists, technicians and the practice of pharmacy in Kansas.

     The Kansas Board of Pharmacy has seen three of its bills advance from the House of Representatives. House Bill 2510 would authorize the Kansas Board of Pharmacy to regulate the training and certification of pharmacy technicians was passed by the House of Representatives but stalled in the Senate Public Health & Welfare Committee last week. The other two bills, House Bill 2561 and House Bill 2609, deal with licensure and collaborative practice between pharmacists and physicians. These bills passed out of the Senate Public Health & Welfare Committee as one bill called Senate Substitute for HB 2146.  During floor debate yesterday an amendment to Senate Substitute for HB 2146 authorizing the Board of Pharmacy to regulate the training and certification of pharmacy technicians was attached and the bill was passed by a vote of 28-7.

    Two KPhA supported bills, HB 2671 updating the Kansas Pharmacy Audit Integrity Act, as well as HB 2688 Continued Access to Community Pharmacy struggled to receive a favorable hearing from the House Insurance Committee Chairman Scott Schwab from Overland Park.  We are currently exploring other avenues to advance these important pieces of legislation.

  • 01/29/2014 8:40 AM | Anonymous

    The American Pharmacists Association (APhA), the leader in pharmacy-based immunization education and advocacy, is pleased to announce an exciting new program for 2014.  Pharmacy-Based Travel Health Services is an innovative and interactive advanced competency training (ACT) program that explores the pharmacist’s role in providing travel health services to patients. This application-based activity is the first step for pharmacists interested in learning the essential skills necessary to successfully provide travel health services.

    The self-study learning portion of the Pharmacy-Based Travel Health Services advanced competency training program is approved for 6 hours (0.6 CEUs) of continuing pharmacy education credit and the live training seminar is approved for 4 hours (0.4 CEUs). The APhA Pharmacy-based Immunization Delivery Certificate Training or other board recognized immunization certificate training program is a pre-requisite for this program. 

    The initial offering of Pharmacy-Based Travel Health Services advanced competency training will be offered in conjunction with the APhA 2014 Annual Meeting and Exposition in Orlando, Florida.  It is scheduled for:

    Friday, March 28

    7:30 am–12:00 pm ET

    Fee: $185 APhA Member / $285 Nonmember

    Registration is currently open for this session:  http://elearning.pharmacist.com/products/1366/pharmacy-based-travel-health-services-apha2014. Please note, space is limited so reserve your seat early.

    Beginning in April 2014, organizations will have the ability to begin the licensure process for the Pharmacy-Based Travel Health Services advanced competency training. It will be available for presentation in mid-June 2014.

    Pharmacy-Based Travel Health Services is developed by the American Pharmacists Association and supported by an unrestricted educational grant from Novartis Vaccines and Diagnostics. APhA would also like to acknowledge Walgreens for its financial contribution to the development of this advanced competency training

  • 01/18/2014 8:43 AM | Anonymous

    Pharmacists ranked as the second most trusted profession for the third consecutive year, according to the results of an annual Gallup Poll that asks consumers to rate 21 professions according to their honesty and ethical standards. Pharmacists were ranked as very high or high in this category by 70% of those surveyed in the 2013 poll. Nurses ranked first at 82%, and grade school teachers tied with pharmacists at 70%. Additional information on the results of the 2013 poll and comparisons with previous years are available on the Gallup Web site.

  • 01/15/2014 4:53 PM | Anonymous

    The Kansas Board of Pharmacy has four inspectors that are currently employed with the Board of Pharmacy. They are Jim Kinderknecht, R.Ph., Carly Haynes, R.Ph., Melissa Martin, and Reyne Kenton. All pharmacies should verify that anyone coming in to do an inspection is a Board inspector. Board inspectors have business cards and are also listed on the Board’s web page. If you have anyone come to your pharmacy claiming to be an inspector and they are not a Board of Pharmacy inspector named above please notify the Board office 785-296-4056 and ask to speak to Debra Billingsley, Executive Secretary or Marty Singleton, Assistant Director. Do not let anyone claiming to be a Board inspector in to your pharmacy until you have verified they are Board inspectors. 

  • 01/09/2014 4:50 PM | Anonymous

    The pharmacists of Northeast Kansas and the Kansas Pharmacists Association are hosting the Northeast Kansas  Legislative Dinner on Thursday, January 9, 2014. The dinner will be at Your Place Or Mine, 501 E 5th St. in Holton Kansas. Agenda topics will include issues affecting pharmacists and the pharmacy profession for the 2014  legislative session. Dinner will be provided by KPSC. Please  plan on attending and invite your local legislators. Use this link from the KPhA website to find out who the legislators in your district are. To RSVP for this event click here or call the KPhA office at 785-228-2327

  • 01/04/2014 9:35 AM | Anonymous
    Kansas Board of Pharmacy has approved and published continuing education violations and penalties for failure to comply with continuing education requirements. Guidelines have been set for failure to comply with the continuing education rules and regulations. Repercussions for a first offense include a fine of $100 for each hour missing and four hours of CE will be mandatory for each one hour of missing or falsified CE. Additionally, CE must be provided to the Board within 30 days of receipt. At the next license renewal, original CE completion certificates must be submitted to the Board for audit. Failure to comply with policy rules and regulations will result in the license being placed on inactive status. To learn more visit the Kansas Board of Pharmacy website.
  • 12/31/2013 9:31 AM | Deleted user
    The 2013 Kansas Pharmacy Law Book is now available for purchase. The cost is $85 for KPhA members and $175 for non-members. The book contains current pharmacy statutes and regulations as well as select related statutes and regulations. It is indexed, tabbed and in a small three ring binder. Included is a CD that can be used to reference it on your computer. A link to an order form is located on this webpage to purchase the law book. Once you complete the order form, KPhA will email an invoice to you for payment. The invoice will contain a link to pay online or you can print and send it with a check. The law books ordered will be shipped once payment is received. Please call Collene at 785-228-2327 if you have questions.
  • 12/04/2013 10:01 AM | Anonymous

    FDA's Bad Ad program is an outreach program designed to educate healthcare providers about the role they can play in helping the agency make sure that prescription drug advertising and promotion is truthful and not misleading. 

    The Bad Ad Program is administered by the agency’s Office of Prescription Drug Promotion (OPDP) in the Center for Drug Evaluation and Research. The program's goal is to help raise awareness among healthcare providers about misleading prescription drug promotion and provide them with an easy way to report this activity to the agency: e-mail BadAd@fda.gov or call 855-RX-BADAD.

    As part of FDA's Bad Ad program, OPDP introduces a new CME/CE e-learning course and case studies to raise healthcare providers (HCP) and HCP students' awareness of misleading prescription drug promotion and other common regulatory concerns. 

    For more information, please visit http://www.fda.gov/badad

  • 11/13/2013 9:30 AM | Anonymous

    The University of Kansas School of Pharmacy presented its Distinguished Service Award to Max Heidrick of Beloit, Kansas on Friday, October 18 at the School of Pharmacy building in Lawrence. Heidrick, a 1971 graduate of the School of Pharmacy, owns S&S Drug in Beloit.

    Established this year, the University of Kansas School of Pharmacy Distinguished Service Award hon­ors individuals who have demonstrated selfless and sustained service and leadership in advancement of the profession, their communities and the School of Pharmacy.

    In addition to serving as a mentor to many School of Pharmacy students over the years, Heidrick has served on countless committees and boards for the pharmacy profession on both the state and national level, including the School of Pharmacy’s Advisory Committee. He has supported the community of Beloit, not only through his downtown pharmacy, by also by donating his time, expertise and resources to local schools and community projects.

    School of Pharmacy Dean Ken Audus said the school has honored distinguished alumni in the past, but not through an annual award.

    “Whether they are practitioners or researchers, those in the pharmacy profession are known for their generosity and service to the community, the profession and the school,” Audus said.  “We decided it was time to recognize them for the amazing work they continue to perform, both professionally and personally.”

    Audus said the selection committee, which included school administrators, faculty, and staff members made an excellent choice when they selected Hedrick to receive the inaugural award.

    “I can think of no one more deserving of this award. The countless hours he has spent mentoring our students over the years, the financial support he has provided to the program and its students, and the contributions he has made to the profession of pharmacy make him the ideal recipient of the first University of Kansas School of Pharmacy Distinguished Service Award,” Audus said.

  • 10/30/2013 11:59 AM | Anonymous

    Type 2 diabetes patients who take their medicine for nocturnal hypertension before bed may have better blood pressure control than those who take their medicine in the morning, according to a study presented on September 26, 2013, at the European Association for the Study of Diabetes annual meeting in Barcelona.  

     Previous research indicates that high blood pressure at night may be a stronger independent risk factor for cardiovascular disease than daytime blood pressure. To investigate new strategies to treat increased nighttime blood pressure, researchers in the current study assessed whether bedtime dosing of once-daily antihypertensive medication reduced nighttime blood pressure without a subsequent increase in daytime blood pressure.  

    The open-label study enrolled 41 type 2 diabetes patients with a nighttime systolic blood pressure reading higher than 120 mm Hg, defined as nocturnal hypertension. Patients were instructed to take all of their once-daily antihypertensive drugs either in the morning or at night for the first 8 weeks, and then to switch to the opposite regimen for the next 8 weeks. Blood pressure measurements, measurements of arterial stiffness, and blood and urine testing were performed at baseline and after each 8-week period. Participants took an average of 3 once-daily antihypertensive drugs.  

     The results indicated that bedtime dosing was associated with a significant decrease in nighttime blood pressure. Average nighttime systolic blood pressure with morning dosing was 125.3 mm Hg, compared with 117.8 mm Hg with bedtime dosingundefineda 7.5–mm Hg difference. When patients took their medications at night, 24-hour systolic blood pressure was also significantly improved when compared with morning dosing (128.7 mm Hg vs. 131.7 mm Hg).  

     In addition, bedtime dosing did not lead to an increase in daytime systolic blood pressure. Average daytime systolic blood pressure for morning dosing was 134.2 mm Hg compared with 133.0 mm Hg for nighttime dosing. In addition, dosing time did not affect morning surge. Similar trends for nighttime and 24-hour decreases without morning increases were seen in diastolic blood pressure, mean arterial pressure, and pulse pressure when medications were taken at night. The results also associated bedtime dosing with increased nocturnal natriuresis.  

    These findings suggest that taking antihypertensive medications before bed may have significant benefits for both nocturnal and 24-hour blood pressure control, without increasing morning blood pressure.  

    “In patients with type 2 diabetes and nocturnal hypertension, dosing of antihypertensive drugs at bedtime may be favorable,” the authors conclude. - See more at: http://www.pharmacytimes.com/news/Taking-Meds-Before-Bed-May-Improve-Nocturnal-Blood-Pressure#sthash.ZEOKCLm4.dpuf

KPhA appreciates the generous support provided by

Diamond Corporate Members
Silver Corporate Members
Bronze Corporate Members
Compliant Pharmacy Alliance
PBA Health
Pharmacists Mutual

Kansas Pharmacists

Preserving, protecting and advancing Kansas pharmacy practice through education, engagement and advocacy.

Contact Us

  • 1020 SW Fairlawn Road
    Topeka, KS 66604
  • 785.228.2327
  • info@ksrx.org
Powered by Wild Apricot Membership Software